Wegovy Without Insurance: Monthly Cost and Coverage

This page belongs to the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the genetic wiring that sits under every metabolic choice. Explore the full Peptides & GLP-1 library.

Cost is one of the most searched aspects of Wegovy, and for people without coverage the numbers online can be confusing. What you actually pay depends on several moving parts: insurance status, the indication your prescription is written for, savings-card eligibility, pharmacy pricing, and whether a compounded alternative is available. This article separates those factors and explains what drives the figures readers see quoted.

The list price, and why almost nobody pays it

Wegovy's list price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. That figure is a starting point rather than a checkout total; it sits before insurance, rebates, manufacturer savings cards, and pharmacy negotiation. Most insured patients pay less, and out-of-pocket cost varies by plan, formulary, prior authorization, and the indication on the prescription.

How coverage decisions get made

Commercial plan coverage hinges on whether the prescription is written for an FDA-approved indication and on the plan's formulary and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while coverage for chronic weight management varies more widely, often carries BMI-based prior authorization, and is sometimes excluded entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. Check directly with your plan.

The savings-card lane

Novo Nordisk publishes a manufacturer savings-card program that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps whose terms change, so verify on the manufacturer site at the time of fill. Independent discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy.

What changed when the shortages ended

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating all legitimate compounding-pharmacy activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified, and these products are not identical to the brand and are priced separately.

Cash-pay scenarios, honestly

With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month, depending on plan terms and caps. With commercial insurance that does not cover the indication, cash-pay cost sits closer to list minus any coupon. Without insurance, cash-pay approaches list price, while compounded alternatives through PlexusDx Weight Management Protocols carry a separate pricing structure published on each product page.

The genetic investment that comes first

Before you spend on a monthly protocol, there is a lower-cost step that informs the whole decision: understanding the biology underneath. The PlexusDx Precision Peptide Genetic Test reads variants in FTO, MC4R, and TCF7L2, covering 14 pathways, 49 peptides, 150+ genetic insights across appetite, satiety, and glucose pathways. It does not predict how you will respond to any drug, does not set a dose, and does not forecast drug outcomes; it is context for a provider conversation. PlexusDx offers semaglutide and tirzepatide through a licensed 503A pathway inside its Weight Management Protocols, including Semaglutide Injection.

How to read a price you find online

Prices quoted online can be genuinely misleading if you do not know what they represent. A single number rarely tells you whether it reflects list price, a coupon-adjusted figure, an insured copay, or a compounded formulation from a licensed pharmacy, each of which sits in a different world. The same medication can appear at wildly different prices depending on which of those a page is describing. That is why the most reliable step is to verify the current cost with the specific pharmacy at the time of fill, and to confirm what product and what pathway the price applies to. Treating an online figure as a rough signal rather than a firm quote will keep expectations honest and prevent unpleasant surprises at checkout.

Frequently Asked Questions

How much does Wegovy cost per month without insurance?

Wegovy's list price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk. Without insurance, cash-pay cost approaches that list figure minus any applicable coupon. Verify the current price with the pharmacy before filling, since published pricing shifts.

Does insurance ever cover Wegovy for weight management?

Sometimes. Coverage depends on the plan, formulary, the FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 drugs for type 2 diabetes; weight-management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there lower-cost alternatives to brand Wegovy?

Licensed 503A compounding pharmacies produce compounded semaglutide and tirzepatide at separate price points from the brand. These products are legally and factually different, not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with per-protocol pricing on each product page.

Should I get the genetic test before paying for a protocol?

It is optional, but it is an upstream step. The Precision Peptide Genetic Test does not predict response and does not forecast drug outcomes; it reads variants such as FTO, MC4R, and TCF7L2 that shape appetite and glucose biology, giving you context for a provider conversation before you commit.

Keep reading across the PlexusDx Education Hub. Return to the Peptides & GLP-1 library.